Table 4.
Risk factor | Adjusted HR (95% CI)* | p-value | |
---|---|---|---|
CYP2C19 | *1/*1 | Reference | |
*1/*R | 1.92 (0.898–4.085) | 0.09 | |
*R/*R | 2.76 (1.112–6.861) | 0.03 | |
Age | 1.66 (1.1442–2.4138) | 0.01 | |
Men | 1.42 (0.706–2.854) | 0.33 | |
Body mass index | 0.79 (0.572–1.0854) | 0.15 | |
Smoking | 1.74 (0.812–3.73) | 0.15 | |
Diabetes | 0.67 (0.344–1.318) | 0.25 | |
Prior CABG | 2.02 (0.266–15.349) | 0.50 | |
Acute coronary syndrome | 1.05 (0.552–1.98) | 0.89 | |
Multivessel disease | 2.02 (0.713–5.739) | 0.19 | |
Stent (n ≥ 2) | 0.48 (0.193–1.182) | 0.11 | |
Haemoglobin | 0.43 (0.3043–0.6081) | <0.01 | |
Creatinine | 1.09 (0.9046–1.3166) | 0.36 | |
LDL cholesterol | 1.06 (0.7574–1.4823) | 0.74 | |
LV ejection fraction | 0.75 (0.578–0.9674) | 0.03 |
*Hazard ratio (HR) with 95% confidence interval (CI).